Steward Partners Investment Advisory’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.3K Hold
3,300
﹤0.01% 3157
2025
Q4
$16.3K Hold
3,300
﹤0.01% 3223
2025
Q3
$14.9K Hold
3,300
﹤0.01% 3219
2025
Q2
$10.3K Sell
3,300
-250
-7% -$704 ﹤0.01% 3197
2025
Q1
$8.91K Hold
3,550
﹤0.01% 3149
2024
Q4
$11K Sell
3,550
-2,500
-41% -$6.4K ﹤0.01% 3057
2024
Q3
$14.4K Hold
6,050
﹤0.01% 2804
2024
Q2
$15.3K Hold
6,050
﹤0.01% 2631
2024
Q1
$17.8K Hold
6,050
﹤0.01% 2561
2023
Q4
$18.2K Hold
6,050
﹤0.01% 2447
2023
Q3
$22.9K Hold
6,050
﹤0.01% 2237
2023
Q2
$26.4K Hold
6,050
﹤0.01% 2154
2023
Q1
$17.4K Buy
+6,050
New +$21.1K ﹤0.01% 2311

Other funds holding DRTS

Steward Partners Investment Advisory's DRTS Position: Q1 2026 in Review

Steward Partners Investment Advisory held its Alpha Tau Medical (DRTS) position steady in Q1 2026 at 3,300 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3157.

Steward Partners Investment Advisory first reported a position in DRTS in Q1 2023 and has held it in 13 quarters since. The position peaked at $26.4K in Q2 2023. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Steward Partners Investment Advisory held 3,300 shares of Alpha Tau Medical worth $23.3K as of Q1 2026.
  • Steward Partners Investment Advisory left its Alpha Tau Medical share count unchanged in Q1 2026.
  • Alpha Tau Medical made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3157 holding.
  • Steward Partners Investment Advisory first reported a position in Alpha Tau Medical in Q1 2023 and has held it in 13 quarters since.
  • Steward Partners Investment Advisory's Alpha Tau Medical position peaked at $26.4K in Q2 2023.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.